We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APP icon
2301
Applovin
APP
$106B
$1.16M ﹤0.01%
59,446
-2,397
-4% -$71.6K
AZZ icon
2302
AZZ Inc
AZZ
$4.52B
$1.16M ﹤0.01%
31,752
-1,123
-3% -$46.8K
DISH
2303
DELISTED
DISH Network Corp.
DISH
$1.16M ﹤0.01%
83,605
+4,609
+6% +$81.5K
RWJ icon
2304
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.11B
$1.16M ﹤0.01%
36,027
-33,873
-48% -$1.23M
EFIV icon
2305
State Street SPDR S&P 500 ESG ETF
EFIV
$1.04B
$1.15M ﹤0.01%
33,901
-44,087
-57% -$1.68M
SUSC icon
2306
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
$1.15M ﹤0.01%
52,943
+26,935
+104% +$624K
ALSN icon
2307
Allison Transmission
ALSN
$10.3B
$1.15M ﹤0.01%
34,129
-4,554
-12% -$170K
TGTX icon
2308
TG Therapeutics
TGTX
$7.46B
$1.15M ﹤0.01%
194,138
+17,494
+10% +$115K
ADTH
2309
DELISTED
AdTheorent Holding Co
ADTH
$1.15M ﹤0.01%
533,612
ADM icon
2310
CALL
Archer Daniels Midland
ADM
$38.7B
$1.15M ﹤0.01%
198,000
NHI icon
2311
National Health Investors
NHI
$3.59B
$1.14M ﹤0.01%
20,213
+637
+3% +$40.1K
CRK icon
2312
Comstock Resources
CRK
$4.1B
$1.14M ﹤0.01%
+65,850
New +$1.09M
CANO
2313
DELISTED
Cano Health, Inc.
CANO
$1.14M ﹤0.01%
1,314
+136
+12% +$85.2K
IETC icon
2314
iShares US Tech Independence Focused ETF
IETC
$727M
$1.14M ﹤0.01%
+28,721
New +$1.3M
EZM icon
2315
WisdomTree US MidCap Fund
EZM
$962M
$1.14M ﹤0.01%
25,817
+26
+0.1% +$1.27K
UPBD icon
2316
Upbound Group
UPBD
$1.14B
$1.13M ﹤0.01%
64,755
-2,681
-4% -$66.8K
RUTH
2317
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$1.13M ﹤0.01%
67,144
+9,956
+17% +$176K
PNNT
2318
Pennant Park Investment Corp
PNNT
$245M
$1.13M ﹤0.01%
207,132
-9,404
-4% -$59.5K
JOE icon
2319
St. Joe Company
JOE
$3.86B
$1.13M ﹤0.01%
35,233
+4,817
+16% +$187K
DCF
2320
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$1.13M ﹤0.01%
165,036
+3,932
+2% +$29K
AMKR icon
2321
Amkor Technology
AMKR
$14.4B
$1.13M ﹤0.01%
65,989
-17,608
-21% -$339K
TNL icon
2322
Travel + Leisure Co
TNL
$4.62B
$1.13M ﹤0.01%
32,958
+3,532
+12% +$149K
TDTF icon
2323
FlexShares iBoxx 5-Year Target Duration TIPS Index Fund
TDTF
$1.04B
$1.12M ﹤0.01%
48,023
-17,520
-27% -$440K
HTLF
2324
DELISTED
Heartland Financial USA, Inc.
HTLF
$1.12M ﹤0.01%
25,893
+1,349
+5% +$59.8K
ANGO icon
2325
AngioDynamics
ANGO
$645M
$1.12M ﹤0.01%
54,818
+10,449
+24% +$229K

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.